Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Side-effect of Antibiotic

Interventions

DRUG

Moxifloxacin 400 mg

The patients receive MXF 400 mg as one hour intravenous infusion at randomized timed intervals prior to liver resection.

Trial Locations (1)

University hospital of the Saarland, Homburg/Saar